Impact of CD38 Deficiency on B Cell Development in CD19 ‐Deficient Mice
Scandinavian Journal of Immunology · 2026-08 · 104 (2)
DOI: 10.1111/sji.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 28.07.2026. Verfasst von A Abrego-Peredo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Químicas, Universidad Autónoma Benito Juárez Oaxaca, Oaxaca, México. Hauptthemen laut MEDLINE: Antigens, CD19, ADP-ribosyl Cyclase 1, B-Lymphocytes, Membrane Glycoproteins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación.
Abstract (Originalsprache)
Physical interaction between the CD38 and CD19 proteins has been previously described. However, this association through the development of B lymphocytes has yet to be thoroughly investigated. To address this, we generated mice with a simultaneous absence of CD38 and CD19 proteins. Our results showed that Cd38 −/− Cd19 −/− mice had reduced survival. We suggest that the combined loss of CD38 and CD19 proteins results in normal B‐cell maturation in the BM compared to WT mice. Nonetheless, these observations differ from those observed in Cd19 −/− mice. In DKO mice, a change in the proportion of the mature B‐cell subset in BM was found in contrast to Cd38 −/− mice. On the periphery, reduced numbers of total splenocytes and total B cells were observed in DKO mice. In addition, some defects in splenic B‐cell development were observed. For example, fewer absolute numbers of T1, T2, and mature B cells were found in comparison with WT mice. However, these subsets have no significant difference compared to Cd19 −/− mice. The MZ B‐cell subset was almost depleted in Cd38−/−Cd19−/− mice, and a contrary effect was observed in FO B cells. Although not many differences were found in the proportions and absolute numbers during the different maturation stages of B cells between DKO and Cd19 −/− mice, a downward trend was observed in some of the steps during B‐cell ontogeny. For this reason, the activation, proliferation, and immunoglobulin secretion, as well as the GC formation and MZ microenvironment in response to different stimuli, must be explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Químicas, Universidad Autónoma Benito Juárez Oaxaca, Oaxaca, México.
- Programa de Doctorado en Ciencias de la Salud, Universidad Veracruzana, Instituto de Ciencias de la Salud, Xalapa, Veracruz, México.
- Unidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México.
- Centro de Investigación y de Estudios Avanzados del IPN, Ciudad de México, México.
- Laboratorio de Biología del Sueño, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.
- Laboratorio de Neuroinmunología, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Ciudad de México, México.
ORCID-Profile: C A Gallardo-Hernández, H Romero-Ramírez
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
Zitieren
APA
Abrego-Peredo, A., Gallardo-Hernández, C. A., López-Herrera, G., Romero-Ramírez, H., García-García, F., Pineda-Olvera, B., & Rodríguez-Alba, J. C. (2026). Impact of CD38 Deficiency on B Cell Development in CD19 ‐Deficient Mice. Scandinavian Journal of Immunology, 104(2). https://doi.org/10.1111/sji.70137
Vancouver
Abrego-Peredo A, Gallardo-Hernández CA, López-Herrera G, Romero-Ramírez H, García-García F, Pineda-Olvera B, et al. Impact of CD38 Deficiency on B Cell Development in CD19 ‐Deficient Mice. Scandinavian Journal of Immunology. 2026;104(2). doi:10.1111/sji.70137
BibTeX
@article{AbregoPeredo2026,
author = {Abrego-Peredo, A and Gallardo-Hernández, C A and López-Herrera, G and Romero-Ramírez, H and García-García, F and Pineda-Olvera, B and Rodríguez-Alba, J C},
title = {Impact of CD38 Deficiency on B Cell Development in CD19 ‐Deficient Mice},
journal = {Scandinavian Journal of Immunology},
year = {2026},
volume = {104},
number = {2},
doi = {10.1111/sji.70137}
}
EUVIMED